TEL AVIV, Israel, September 25, 2015 /PRNewswire/ --
Elbit Imaging Ltd. ("EI" or the
"Company") (TASE, NASDAQ: EMITF)
announced today the filing of a Motion for approval of a derivative
claim against the Company and its directors (the "Motion" and the
"Derivative claim," respectively) on behalf of the Company. The
Motion was filed by Mr. Shlomi Kelsi, a director of the
Company.
The Claim alleges, among other things, a breach of fiduciary
duty and duty of care by the Company's directors as a result of
resolutions that were taken in recent Board meetings. The Claim
further alleges, that such resolutions should be void or at least
to be declared as voidable. The regard resolutions mainly
concerning the approval of the board to convey a shareholders
meeting of the Company to re-elect the Company's board members, as
described in the Company's announcement dated September 3, 2015, and the convening of
extraordinary general meeting in Plaza Centers NV a subsidiary of
the Company ("Plaza") to dismiss certain directors
from their position as board members in Plaza, as described in the
Company's announcement dated September 21,
2015.
The Applicants also filed an interim injunction for temporary
remedies to postpone the general meeting of the Company from
discussing and voting on the size of the Company's board of
directors and from re-electing of the Company's board of directors,
and to instruct the Company to withdraw its request to convene a
general meeting in Plaza or to instruct the Company to vote against
any change in Plaza's board of directors in such general
meeting.
The Applicants further requested a splitting of remedies and a
reimbursement of expenses and legal fees.
At this preliminary stage, the Company is currently reviewing
and evaluating the Motion and will submit its response
accordingly.
About Elbit Imaging Ltd.
Elbit Imaging Ltd. operates in the following principal fields of
business: (i) Commercial centers - initiation, construction, and
sale of commercial centers and other mixed-use property projects,
predominantly in the retail sector, located in Central and
Eastern Europe and in India. In certain circumstances and depending
on market conditions, the Group operates and manages commercial
centers prior to their sale. (ii) Hotels - hotels operation and
management. (iii) Medical industries and devices - (a) research and
development, production and marketing of magnetic resonance imaging
guided focused ultrasound treatment equipment, and (b) development
of stem cell population expansion technologies and stem cell
therapy products for transplantation and regenerative medicine.
(iv) Residential projects - initiation, construction and sale of
residential units or plots designated for residential located
primarily in India.
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995
Any forward-looking statements in our releases include
statements regarding the intent, belief or current expectations of
Elbit Imaging Ltd. and our management about our business, financial
condition, results of operations, and its relationship with its
employees and the condition of our properties. Words such as
"believe," "would,"
"expect," "intend,"
"estimate" and similar expressions are
intended to identify forward-looking statements but are not the
exclusive means of identifying such statements. Actual results may
differ materially from those projected, expressed or implied in the
forward-looking statements as a result of various factors
including, without limitation, the factors set forth
in our filings with the Securities and Exchange Commission
including, without limitation, Item 3.D of our annual report on
Form 20-F for the fiscal year ended December
31, 2014, under the caption
"Risk Factors." Any forward-looking
statements contained in our releases speak only as of the date of
such release, and we caution existing and prospective investors not
to place undue reliance on such statements. Such forward-looking
statements do not purport to be predictions of future events or
circumstances, and therefore, there can be no assurance that any
forward-looking statement contained our releases will prove to be
accurate. We undertake no obligation to update or revise any
forward-looking statements.
For Further Information:
Company Contact
Ron Hadassi
Chairman of the Board of Directors
Tel: +972-3-608-6048
Fax: +972-3-608-6050
ron@elbitimaging.com
SOURCE Elbit Imaging Ltd.